Advertisement

Anesthesia

Advertisement

Rolapitant, a potent, selective NK1 receptor antagonist, reduces the incidence of vomiting in a dose-dependent manner after surgery, according to a study published in the March 2011 issue of Anesthesia & Analgesia.

Advertisement